Tata Memorial Centre Expands Care with New Multispecialty Hospital at ACTREC, Kharghar
In a landmark development for healthcare in Navi Mumbai, the Tata Memorial Centre (TMC) has announced plans to establish its first multispecialty hospital at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Kharghar. This new facility is designed to offer comprehensive medical care to cancer patients, addressing both cancer-related and non-cancer health issues under one roof.
Currently, patients undergoing treatment at ACTREC often face the added challenge of being referred to other hospitals for complications related to the heart, lungs, kidneys, and other vital organs. The upcoming 12-storey multispecialty block, with over 150 beds, will house specialised clinics to manage these conditions in-house, ensuring holistic treatment and reducing the need for external referrals. The hospital is expected to be operational within the next three years. “Cancer is often an age-related disease, and its incidence increases alongside other health conditions. Treatments like chemotherapy can cause complications that affect vital organs. This in-house multispecialty block will help manage such adverse effects and improve patient outcomes,” explained Dr Pankaj Chaturvedi, Director of ACTREC.
Beyond the multispecialty hospital, TMC has unveiled a series of initiatives aimed at expanding patient support and advancing cancer research. A key focus is increasing patient accommodation: the Infosys Foundation is backing the Asha Nivas facility, which offers free or subsidised housing for 300 patients and caregivers. Additionally, the upcoming 11-storey St. Jude’s Children’s Cancer Centre, scheduled to open by mid-2025, will provide accommodation for 220 children and their families. ACTREC continues to strengthen its position as a leader in cancer research through the Cancer Research Institute (CRI), where cutting-edge studies in cancer biology, treatment, and prevention are conducted. The facility uniquely integrates basic and clinical research, fostering groundbreaking discoveries.
A significant upcoming addition is the Radiological Research Unit, set to become one of the largest nuclear medicine treatment centres globally. This unit will feature 41 specialised therapy beds and an in-house cyclotron for producing medical isotopes, enhancing cancer diagnostics and treatment. To support its advanced research efforts, ACTREC will also commission a high-performance computing facility, enabling breakthroughs in genomics, artificial intelligence-driven diagnostics, and drug discovery. Another major project underway is a 400-bed hospital dedicated to blood cancer treatment for both children and adults, expected to be completed by December 2025. “Blood cancers and paediatric cancers are among the most curable cancers in the world. This new unit will allow us to provide focused, high-quality care,” said Dr Naveen Khattry, Deputy Director at ACTREC.
ACTREC’s expertise in bone marrow transplantation is well-established, with over 1,100 transplants conducted since 2007. The facility is now expanding its cellular therapy programmes, including CAR-T cell therapy—a revolutionary immunotherapy for treating blood cancers. With these transformative initiatives, Tata Memorial Centre is not only enhancing cancer care but also setting new benchmarks for integrated healthcare and advanced medical research in India.
